chr12-88148374-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM2PP3_ModerateBS1_Supporting
The NM_181783.4(TMTC3):āc.59A>Gā(p.Tyr20Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000412 in 1,613,640 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: š 0.00028 ( 0 hom., cov: 32)
Exomes š: 0.00043 ( 0 hom. )
Consequence
TMTC3
NM_181783.4 missense
NM_181783.4 missense
Scores
12
4
2
Clinical Significance
Conservation
PhyloP100: 5.95
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.842
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000282 (43/152246) while in subpopulation NFE AF= 0.000603 (41/68008). AF 95% confidence interval is 0.000457. There are 0 homozygotes in gnomad4. There are 12 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMTC3 | NM_181783.4 | c.59A>G | p.Tyr20Cys | missense_variant | 2/14 | ENST00000266712.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMTC3 | ENST00000266712.11 | c.59A>G | p.Tyr20Cys | missense_variant | 2/14 | 1 | NM_181783.4 | P1 | |
TMTC3 | ENST00000547034.5 | c.59A>G | p.Tyr20Cys | missense_variant, NMD_transcript_variant | 2/12 | 1 | |||
TMTC3 | ENST00000549011.5 | c.59A>G | p.Tyr20Cys | missense_variant | 2/4 | 4 | |||
TMTC3 | ENST00000551088.1 | c.59A>G | p.Tyr20Cys | missense_variant | 2/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152128Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
43
AN:
152128
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000215 AC: 54AN: 251252Hom.: 1 AF XY: 0.000191 AC XY: 26AN XY: 135800
GnomAD3 exomes
AF:
AC:
54
AN:
251252
Hom.:
AF XY:
AC XY:
26
AN XY:
135800
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000426 AC: 622AN: 1461394Hom.: 0 Cov.: 30 AF XY: 0.000431 AC XY: 313AN XY: 726996
GnomAD4 exome
AF:
AC:
622
AN:
1461394
Hom.:
Cov.:
30
AF XY:
AC XY:
313
AN XY:
726996
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000282 AC: 43AN: 152246Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74444
GnomAD4 genome
AF:
AC:
43
AN:
152246
Hom.:
Cov.:
32
AF XY:
AC XY:
12
AN XY:
74444
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
4
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
24
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 18, 2022 | This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 20 of the TMTC3 protein (p.Tyr20Cys). This variant is present in population databases (rs140803138, gnomAD 0.04%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with TMTC3-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Lissencephaly 8 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 04, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
.;H;.
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
1.0
.;D;.
Vest4
0.89
MVP
MPC
1.2
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at